Clinical Trials at Hope and Healing Cancer Services
As of August 2026, 21 paid clinical trials are recruiting at Hope and Healing Cancer Services, located at 950 N YORK RD STE 201A, HINSDALE, IL 60521-8609, phone (630) 560-0121 in Hinsdale, Illinois. Active studies at this site cover conditions such as Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC) and Non-small Cell Lung Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
21 clinical trials at Hope and Healing Cancer Services
·Clear filters·Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
GEMINI-NSCLC: NSCLC Biomarker Study
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Caris Biorepository Research Protocol
Prospective Study to Assess a Diagnostic Aid for Cancer
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Common conditions studied in Hinsdale
- Non-Small Cell Lung Cancer (5 active studies)
- Cancer (3 active studies)
- Carcinoma, Non-Small-Cell Lung (NSCLC) (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Hinsdale
- AstraZeneca
- Pfizer
- AbbVie
- BeOne Medicines
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Hinsdale?
There are approximately 52 recruiting clinical trials in Hinsdale, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hinsdale pay participants?
Most recruiting trials in Hinsdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hinsdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hinsdale?
The most common conditions under active study in Hinsdale include Non-Small Cell Lung Cancer (5), Cancer (3), Carcinoma, Non-Small-Cell Lung (NSCLC) (3), Non-small Cell Lung Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hinsdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hinsdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hinsdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hinsdale?
Recruiting research sites in Hinsdale include Hope and Healing Cancer Services, UChicago Medicine AdventHealth Cancer Institute Hinsdale, Hope And Healing Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hinsdale right now?
The largest active categories in Hinsdale are Cancer & tumors (30), Diabetes & metabolic (1), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Hope and Healing Cancer Services?
Hope and Healing Cancer Services is located at 950 N YORK RD STE 201A, HINSDALE, IL 60521-8609. Use the Google Maps link in the intro above to get directions.
How do I contact Hope and Healing Cancer Services?
You can reach Hope and Healing Cancer Services by phone at (630) 560-0121. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.